Oral Ribavirin is a Highly Efficacious Treatment for Lower Respiratory Tract Infection due to Respiratory Syncytial or Parainfluenza Virus in Allogeneic Stem Cell Transplant Recipients

被引：0
|
作者：
Tsonis, Ioannis [1 ]
Baltadakis, Ioannis [1 ]
Stamouli, Maria [2 ]
Gkirkas, Konstantinos [2 ]
Economopoulou, Christina [3 ]
Gardeli, Dimitra [1 ]
Thomopoulos, Thomas [2 ]
Paisiou, Anna [3 ]
Oikonomopoulou, Dimitra [1 ]
Tzenou, Tatiana [1 ]
Siafakas, Nikolaos [2 ]
Pournaras, Spyridon [2 ]
Antoniadou, Anastasia [2 ]
Karagiannidi, Aggeliki [2 ]
Grispou, Eirini [1 ]
Meletiadis, Joseph [2 ]
Kavatha, Dimitra [2 ]
Gigantes, Stavros [2 ]
Goussetis, Evgenios [3 ]
Karakasis, Dimitrios [1 ]
Tsirigotis, Panagiotis [2 ]
机构：
[1] Evangelismos Med Ctr, Athens, Greece
[2] Natl & Kapodistrian Univ Athens, Attikon Univ Hosp, Athens, Greece
[3] Aghia Sophia Children Hosp, Athens, Greece
来源：
BONE MARROW TRANSPLANTATION | 2020年 / 55卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
P386
引用
收藏
页码：473 / 474
页数：2
相关论文
共 50 条
  • [1] Oral ribavirin is a highly effective treatment for lower respiratory tract infections due to respiratory syncytial virus or parainfluenza after allogeneic stem cell transplantation
    Stamouli, Maria
    Tsonis, Ioannis
    Gkirkas, Konstantinos
    Economopoulou, Christina
    Siafakas, Nikolaos
    Pournaras, Spyridon
    Antoniadou, Anastasia
    Chondropoulos, Spyros
    Karagiannidi, Angeliki
    Meletiadis, Josef
    Gigantes, Stavros
    Baltadakis, Ioannis
    Goussetis, Evgenios
    Karakasis, Dimitrios
    Tsirigotis, Panagiotis
    [J]. BONE MARROW TRANSPLANTATION, 2021, 56 (02) : 511 - 513
  • [2] Oral ribavirin is a highly effective treatment for lower respiratory tract infections due to respiratory syncytial virus or parainfluenza after allogeneic stem cell transplantation
    Maria Stamouli
    Ioannis Tsonis
    Konstantinos Gkirkas
    Christina Economopoulou
    Nikolaos Siafakas
    Spyridon Pournaras
    Anastasia Antoniadou
    Spyros Chondropoulos
    Angeliki Karagiannidi
    Josef Meletiadis
    Stavros Gigantes
    Ioannis Baltadakis
    Evgenios Goussetis
    Dimitrios Karakasis
    Panagiotis Tsirigotis
    [J]. Bone Marrow Transplantation, 2021, 56 : 511 - 513
  • [3] Oral Ribavirin with or without the Addition of Immune Globulin for the Treatment of Lower Respiratory Tract Infections Due to Respiratory Syncytial Virus or Parainfluenza in Patients after Allogeneic Stem Cell Transplantation
    Stamouli, Maria
    Tsonis, Ioannis
    Gkirkas, Konstantinos
    Economopoulou, Christina
    Thomopoulos, Thomas
    Paisiou, Anna
    Siafakas, Nikolaos
    Pournaras, Spyridon
    Antoniadou, Anastasia
    Karagiannidi, Aggeliki
    Meletiadis, Joseph
    Kavatha, Dimitra
    Vassilopoulos, George
    Gigantes, Stavros
    Baltadakis, Ioannis
    Goussetis, Evgenios
    Karakasis, Dimitrios
    Tsirigotis, Panagiotis
    [J]. BLOOD, 2019, 134
  • [4] Efficacy of Oral Ribavirin in Lung Transplant Patients With Respiratory Syncytial Virus Lower Respiratory Tract Infection
    Pelaez, Andres
    Lyon, G. Marshall
    Force, Seth D.
    Ramirez, Allan M.
    Neujahr, David C.
    Foster, Marianne
    Naik, Priyumvada M.
    Gal, Anthony A.
    Mitchell, Patrick O.
    Lawrence, E. Clinton
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2009, 28 (01): : 67 - 71
  • [5] Oral and Inhaled Ribavirin Treatment for Respiratory Syncytial Virus Infection in Lung Transplant Recipients
    Permpalung, Nitipong
    Thaniyavarn, Tany
    Saullo, Jennifer L.
    Arif, Sana
    Miller, Rachel A.
    Reynolds, John M.
    Alexander, Barbara D.
    [J]. TRANSPLANTATION, 2020, 104 (06) : 1280 - 1286
  • [6] Respiratory syncytial virus lower respiratory tract infection in a pediatric liver transplant recipient treated with oral ribavirin
    Keck, Megan
    Mindru, Cezarina
    Kalil, Andre C.
    Mercer, David F.
    Florescu, Diana F.
    [J]. PEDIATRIC TRANSPLANTATION, 2012, 16 (08) : E348 - E351
  • [7] Oral ribavirin therapy for lower respiratory tract infection of respiratory syncytial virus complicating bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation
    Mori, Takehiko
    Nakamura, Yukinori
    Kato, Jun
    Yamane, Akiko
    Aisa, Yoshinobu
    Takeshita, Kei
    Okamoto, Shinichiro
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2011, 93 (01) : 132 - 134
  • [8] Oral Ribavirin for the Treatment of Respiratory Syncytial Virus Infection in Allogeneic Stem Cell Transplant Recipients-Utility of the Immunodeficiency Scoring Index for Risk Stratification
    Damlaj, Moussab
    Bartoo, Gabriel
    Gijima, Desire
    Hashmi, Shahrukh
    Litzow, Mark R.
    Hogan, William
    Patnaik, Mrinal
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (02) : S173 - S174
  • [9] Treatment of respiratory tract infections caused by respiratory syncytial virus and/or adenovirus with intravenous ribavirin in recipients of allogeneic hematopoietic stem cell transplants
    Schleuning, M
    Buxbaum-Conradi, H
    Jäger, G
    Kolb, HJ
    [J]. BONE MARROW TRANSPLANTATION, 2003, 31 : S87 - S87
  • [10] Empiric treatment of respiratory syncytial virus infection in adult stem cell transplant recipients with ribavirin and palivizumab.
    Stacy, T
    Connaghan, DG
    Holland, HK
    [J]. BLOOD, 2000, 96 (11) : 343B - 343B
12345